{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T12:12:30Z","timestamp":1789992750777,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004572","name":"National Health Commission of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004572","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajkd.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Kidney Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.ajkd.2026.05.009","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T06:48:55Z","timestamp":1784270935000},"page":"521-530.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time in Target Range for Hemoglobin A1c and Systolic Blood Pressure: Association With Adverse Kidney Events"],"prefix":"10.1053","volume":"88","author":[{"given":"Xi","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1045-8309","authenticated-orcid":false,"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10225","key":"10.1053\/j.ajkd.2026.05.009_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"issue":"9889","key":"10.1053\/j.ajkd.2026.05.009_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"7","key":"10.1053\/j.ajkd.2026.05.009_bib3","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9731","key":"10.1053\/j.ajkd.2026.05.009_bib4","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","author":"Matsushita","year":"2010","journal-title":"Lancet"},{"key":"10.1053\/j.ajkd.2026.05.009_bib5","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"10.1053\/j.ajkd.2026.05.009_bib6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"issue":"25","key":"10.1053\/j.ajkd.2026.05.009_bib7","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"De Boer","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1053\/j.ajkd.2026.05.009_bib8","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2337\/dc15-2322","article-title":"Long-term benefits of intensive glucose control for preventing end-stage kidney disease: ADVANCE-ON","volume":"39","author":"Wong","year":"2016","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1053\/j.ajkd.2026.05.009_bib9","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2215\/CJN.06200518","article-title":"Long-term effects of intensive glycemic and blood pressure control and fenofibrate use on kidney outcomes","volume":"13","author":"Mottl","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ajkd.2026.05.009_bib10","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/ki.2011.415","article-title":"Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients","volume":"81","author":"Ismail-Beigi","year":"2012","journal-title":"Kidney Int"},{"issue":"7","key":"10.1053\/j.ajkd.2026.05.009_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"22","key":"10.1053\/j.ajkd.2026.05.009_bib12","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ajkd.2026.05.009_bib13","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.009_bib14","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/dc12-2264","article-title":"HbA1c variability as an independent correlate of nephropathy, but not retinopathy, in patients with type 2 diabetes: the Renal Insufficiency and Cardiovascular Events (RIACE) Italian multicenter study","volume":"36","author":"Penno","year":"2013","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1053\/j.ajkd.2026.05.009_bib15","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/ndt\/gfz093","article-title":"Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients","volume":"35","author":"Li","year":"2020","journal-title":"Nephrol Dial Transplant"},{"issue":"15","key":"10.1053\/j.ajkd.2026.05.009_bib16","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.009_bib17","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/dc21-0292","article-title":"Increased hemoglobin A1c time in range reduces adverse health outcomes in older adults with diabetes","volume":"44","author":"Prentice","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1053\/j.ajkd.2026.05.009_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1161\/HYPERTENSIONAHA.122.20141","article-title":"Systolic blood pressure time in target range and major adverse kidney and cardiovascular events","volume":"80","author":"Buckley","year":"2023","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.009_bib19","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.25354","article-title":"Glycated hemoglobin A1c time in range and dementia in older adults with diabetes","volume":"7","author":"Underwood","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1053\/j.ajkd.2026.05.009_bib20","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jacc.2021.01.014","article-title":"Systolic blood pressure time in target range and cardiovascular outcomes in patients with hypertension","volume":"77","author":"Fatani","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1053\/j.ajkd.2026.05.009_bib21","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/HYPERTENSIONAHA.122.20711","article-title":"Systolic blood pressure time in target range and cognitive outcomes: insights from the SPRINT MIND Trial","volume":"80","author":"Li","year":"2023","journal-title":"Hypertension"},{"issue":"12a","key":"10.1053\/j.ajkd.2026.05.009_bib22","doi-asserted-by":"crossref","first-page":"21i","DOI":"10.1016\/j.amjcard.2007.03.003","article-title":"Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods","volume":"99","author":"Buse","year":"2007","journal-title":"Am J Cardiol"},{"issue":"24","key":"10.1053\/j.ajkd.2026.05.009_bib23","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1053\/j.ajkd.2026.05.009_bib24","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1161\/HYPERTENSIONAHA.123.21651","article-title":"Systolic blood pressure time in target range and incident atrial fibrillation in patients with hypertension: insights from the SPRINT Trial","volume":"80","author":"Wang","year":"2023","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ajkd.2026.05.009_bib25","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1161\/HYPERTENSIONAHA.124.24013","article-title":"Time in target range for blood pressure and adverse health outcomes: a systematic review","volume":"82","author":"Wang","year":"2025","journal-title":"Hypertension"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.009_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002738","article-title":"Association of hemoglobin A1c time in range with risk for diabetes complications","volume":"10","author":"Mohr","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"19","key":"10.1053\/j.ajkd.2026.05.009_bib27","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1097\/CM9.0000000000002073","article-title":"Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"135","author":"Qu","year":"2022","journal-title":"Chin Med J (Engl)"},{"issue":"3","key":"10.1053\/j.ajkd.2026.05.009_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1053\/j.ajkd.2023.03.007","article-title":"Long-term visit-to-visit variability in hemoglobin A1c and kidney-related outcomes in persons with diabetes","volume":"82","author":"Xu","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.009_bib29","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1053\/j.ajkd.2022.08.017","article-title":"Short-term blood pressure variability and incident CKD in patients with hypertension: findings from the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study","volume":"81","author":"Jhee","year":"2023","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"10.1053\/j.ajkd.2026.05.009_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/j.ajkd.2014.06.008","article-title":"Visit-to-visit variability in blood pressure and kidney and cardiovascular outcomes in patients with type 2 diabetes and nephropathy: a post hoc analysis from the RENAAL study and the Irbesartan Diabetic Nephropathy Trial","volume":"64","author":"McMullan","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1053\/j.ajkd.2026.05.009_bib31","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.kint.2023.12.008","article-title":"Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression","volume":"105","author":"Park","year":"2024","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ajkd.2026.05.009_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2019.06.009","article-title":"Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency","volume":"75","author":"Levey","year":"2020","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1053\/j.ajkd.2026.05.009_bib33","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"}],"container-title":["American Journal of Kidney Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626010036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272638626010036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:39:09Z","timestamp":1789990749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272638626010036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0272638626010036"],"URL":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.05.009","relation":{},"ISSN":["0272-6386"],"issn-type":[{"value":"0272-6386","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Time in Target Range for Hemoglobin A1c and Systolic Blood Pressure: Association With Adverse Kidney Events","name":"articletitle","label":"Article Title"},{"value":"American Journal of Kidney Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ajkd.2026.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}